ticlopidine has been researched along with Anemia, Sickle Cell in 6 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ticlopidine treatment did not significantly improve platelet life-span or factor VIII levels, though it was associated with reduced values of beta TG and PF4." | 2.65 | A double-blind trial of ticlopidine in sickle cell disease. ( Al-Hasani, SF; Kioy, P; Savidge, GF; Semple, MJ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Polanowska-Grabowska, R | 1 |
| Wallace, K | 1 |
| Field, JJ | 1 |
| Chen, L | 1 |
| Marshall, MA | 1 |
| Figler, R | 1 |
| Gear, AR | 1 |
| Linden, J | 1 |
| Cabannes, R | 2 |
| Lonsdorfer, J | 2 |
| Castaigne, JP | 3 |
| Ondo, A | 1 |
| Plassard, A | 1 |
| Zohoun, I | 1 |
| Day, HJ | 1 |
| Semple, MJ | 1 |
| Al-Hasani, SF | 1 |
| Kioy, P | 1 |
| Savidge, GF | 1 |
| Lenormand, E | 1 |
| Otayeck, A | 1 |
| Bogui, P | 1 |
| Dosso, Y | 1 |
| Sablayrolles, M | 1 |
| Wajcman, H | 1 |
| Labie, D | 1 |
1 review available for ticlopidine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Overview: clinical experiences with ticlopidine.
Topics: Anemia, Sickle Cell; Anticoagulants; Arterial Occlusive Diseases; Cerebrovascular Disorders; Clinica | 1984 |
3 trials available for ticlopidine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises.
Topics: Anemia, Sickle Cell; Anticoagulants; Clinical Trials as Topic; Double-Blind Method; Humans; Thiophen | 1984 |
Overview: clinical experiences with ticlopidine.
Topics: Anemia, Sickle Cell; Anticoagulants; Arterial Occlusive Diseases; Cerebrovascular Disorders; Clinica | 1984 |
A double-blind trial of ticlopidine in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Anticoagulants; Blood Coagulation Factors; Blood Platelets; Cell Surviva | 1984 |
3 other studies available for ticlopidine and Anemia, Sickle Cell
| Article | Year |
|---|---|
P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.
Topics: Anemia, Sickle Cell; Animals; Antibodies; Blood Platelets; Capillary Permeability; Case-Control Stud | 2010 |
Beneficial effects of ticlopidine on cardiopulmonary function of sickle cell patients not in crisis.
Topics: Adult; Anemia, Sickle Cell; Anticoagulants; Heart; Heart Rate; Humans; Lung; Oxygen; Physical Exerti | 1984 |
Membrane expansion as a mechanism explaining the antisickling action of ticlopidine observed in vitro.
Topics: Anemia, Sickle Cell; Antisickling Agents; Densitometry; Erythrocyte Membrane; Humans; Kinetics; Osmo | 1985 |